Zum Hauptinhalt springen
Dr Mohamad Abdel-Hadi
Vertrauenswert 8/100

Dr Mohamad Abdel-Hadi

Onkologie · Dammam

👤 5 Jahre Erfahrung

10,610+ Patients seen
5 Years in practice
14 Publications
2 Languages spoken

Über uns

Dr Mohamad Abdel-Hadi is a distinguished Consultant in Gynecologic Oncology with extensive experience in the field of women's health and cancer care. He is recognised for his leadership in establishing specialised oncology services within tertiary care settings in the region. His professional focus lies in the comprehensive management of gynaecological malignancies, where he combines clinical expertise with a dedication to patient-centred care. Dr Abdel-Hadi is also deeply involved in medical education, having served as a programme director for fellowship training, ensuring the next generation of specialists adheres to high standards of practice.
In his clinical practice, Dr Abdel-Hadi specialises in the diagnosis, surgical treatment, and long-term management of cancers affecting the female reproductive system, including ovarian, uterine, and cervical malignancies. He employs a multidisciplinary approach to complex cases, working closely to tailor treatment plans that address both the medical and emotional needs of his patients. His expertise extends to advanced surgical techniques required for intricate pelvic procedures, aiming to achieve the best possible oncological outcomes while preserving quality of life.
Dr Abdel-Hadi completed his medical training with an MBBS from the University of Jordan, followed by a residency in Obstetrics and Gynaecology at Jordan University Hospital. He further advanced his sub-specialisation by completing a Fellowship in Gynecologic Oncology at the Sydney Cancer Center and Royal Prince Alfred Hospital in Australia. He holds board certification in Obstetrics and Gynaecology and maintains an active interest in clinical research, particularly regarding risk factors for ovarian cancer in the region.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Mohamad Abdel-Hadi

Ausbildung & Training

  1. 2011–2017 MD · Medicine and Surgery
    Universitat de València, Dammam (SA)
  2. 2017–2021 Residency · Onkologie
    Universitat de Barcelona, Dammam (SA)

Karriere & Anstellungen

  1. 2021-09–2022-08 Junior consultant
    Universitat de València Teaching Hospital — Onkologie

Lizenzen & Versicherung

Medizinische Lizenzen

SA — Organización Médica Colegial de España (OMC)
#SA-766243 active · expires 2028-12-31

Facharztzertifikate

European Board of Onkologie
#EB-9B1A9AB8 · issued 2022 · renewal 2032
Berufshaftpflichtversicherung: AmTrust Europe · 3,000,000 EUR Deckung · No claims on file

Durchgeführte Verfahren

VerfahrenCodeLebenszeit-Anzahl
GP consultation 99213 573
Annual physical exam 99395 723
Vaccination administration 90471 2,867
Minor procedure (skin) 17110 1,668

Leistungen & Preise

LeistungDauerModalitätPreis
New patient consultation (60m) 60 Min. in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 Min. in_clinic|telemed|phone 90.00 EUR
Vaccination administration 60 Min. in_clinic 270.00 EUR
Minor procedure (skin) 90 Min. in_clinic 360.00 EUR

Praxis, Team & in der Praxis

Mohamad Abdel-Hadi in consultation
IN OFFICE
Mohamad Abdel-Hadi with the team
WITH TEAM
Mohamad Abdel-Hadi at a conference
CONFERENCE

Videos

introduction · 145s
Meet Mohamad Abdel-Hadi

Forschung & Publikationen

h-Index: 21 · i10: 11

  1. Long-term follow-up of Onkologie across SA
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2026
    DOI: 10.6175/euroclin.2026.0 · PMID: 33600566 · zitiert von 141
  2. Validation of clinical scoring in Onkologie
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2025
    DOI: 10.5933/euroclin.2025.1 · PMID: 33929234 · zitiert von 39
  3. Long-term follow-up of Onkologie across SA
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2024
    DOI: 10.6962/euroclin.2024.2 · PMID: 35975720 · zitiert von 9
  4. Validation of clinical scoring in Onkologie
    Mohamad Abdel-Hadi, et al. · European Journal of Medicine, 2023
    DOI: 10.5524/euroclin.2023.3 · PMID: 39102562 · zitiert von 99

Eingeladene Vorträge

  • Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
  • Single-centre experience in Onkologie National Society Meeting · Dammam · 2023 · oral abstract

Auszeichnungen & Mitgliedschaften

Auszeichnungen

  • 🏆 Top-rated Onkologie — Dammam · EuroClinics Patient Choice · 2025 · regional

Gesellschaftsmitgliedschaften

  • WONCA Europe — Family Doctors — Member · Seit 2022
  • national college of family doctors — Member · Seit 2022
  • European Union of Medical Specialists (UEMS) — Member · Seit 2022

Artikel dieses Arztes

  • Patient education Patient guide to Onkologie
  • Awareness When should you see a onkologie?

Für internationale Patienten

Koordinator
Patient liaison · mohamad.abdel.hadi@euroclinics.example

Standort

1 Tag

Patientenbewertungen

Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
20 – 4.000 Zeichen

Einreichungen werden moderiert und können 24-72 Stunden dauern, bis sie öffentlich erscheinen. Patientenidentifizierende Informationen sollten nicht enthalten sein.

Aktuelle Bewertungen

  • ★★★★★ ✓ Verifiziert
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Verifiziert
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Verifiziert
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Ähnliche Spezialisten

Alle durchsuchen →